Search - tctmd.com

Displaying 821 - 840 of 2488

Sort: Relevancy | Date

News Daily News

Updated TAVR Consensus Statement Keeps Volume Requirements but Shifts Focus to Quality

Todd Neale

July 18, 2018

News Daily News

OCT, IVUS Each Boost Long-term Outcomes When Used to Guide PCI, Study Suggests

Todd Neale

July 16, 2018

News Daily News

ORBITA Redux: Lancet Correspondence Takes Talk of the Sham-Controlled PCI Trial to Further Heights

Michael O'Riordan

July 10, 2018

News Daily News

ICD Use Curbed at Hospitals After US Department of Justice Scrutiny

Caitlin E. Cox

July 05, 2018

News Daily News

Norepinephrine Bests Epinephrine in Battle of the Vasopressors in Cardiogenic Shock

L.A. McKeown

July 03, 2018

News Daily News

Once Again, ISCHEMIA Trial Feels the Squeeze

Michael O'Riordan

June 29, 2018

News Daily News

Little Impact of Medicare ACOs on Low- and High-Value Revascularization Decisions

L.A. McKeown

June 22, 2018

News Features

The M Word: Is Routine Transfemoral PCI Defensible in 2018?

Todd Neale

June 08, 2018

News Daily News

Platelet Reactivity Linked With Ischemic Stroke Risk Post-DES Implantation: ADAPT-DES Substudy

Yael L. Maxwell

June 08, 2018

News Daily News

Shortfalls in MI Care Hit Lowest Socioeconomic Groups the Hardest

L.A. McKeown

June 06, 2018

News Daily News

Similar Rate of Radial Artery Occlusion After Manual and Mechanical Compression

Michael O'Riordan

June 05, 2018

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for May 2018

Caitlin E. Cox

June 01, 2018

News Conference News EuroPCR 2018

STEMI Patients With Persistent Ischemia After PCI: A Potential Target for IABP?

Caitlin E. Cox

May 31, 2018

News Conference News EuroPCR 2018

ORBITA Deep Dive Highlights Treatment Choices, Social Media, and Ethics

Michael O'Riordan

May 31, 2018

News Conference News EuroPCR 2018

DCBs for CAD in Certain Patients With Large Vessel De Novo Disease? DEBUT Says Yes

Caitlin E. Cox

May 25, 2018

News Industry News

PiCSO therapy reduces infarct size in STEMI patients. Miracor Medical announces new publication at EuroPCR

May 24, 2018

News Conference News EuroPCR 2018

‘Transient’ STEMI Patients Can Be Immediately Treated or Safely Deferred to Next Day

Michael O'Riordan

May 24, 2018

News Conference News EuroPCR 2018

Modest Benefit of PCI Over Medical Therapy in Patients With ‘Grey Zone’ FFR Lesions

Michael O'Riordan

May 23, 2018

News Conference News EuroPCR 2018

FFR in PCI for Stable CAD: Lasting Benefit Shown by FAME 2, SCAAR Data

Caitlin E. Cox

May 22, 2018

News Conference News EuroPCR 2018

New ORBITA Insights: Invasive Physiology Tests Track Closely With Ischemia, but Not Symptom Improvement

Shelley Wood

May 22, 2018

Advertisement

Updated TAVR Consensus Statement Keeps Volume Requirements but Shifts Focus to Quality

OCT, IVUS Each Boost Long-term Outcomes When Used to Guide PCI, Study Suggests

ORBITA Redux: Lancet Correspondence Takes Talk of the Sham-Controlled PCI Trial to Further Heights

ICD Use Curbed at Hospitals After US Department of Justice Scrutiny

Norepinephrine Bests Epinephrine in Battle of the Vasopressors in Cardiogenic Shock

Once Again, ISCHEMIA Trial Feels the Squeeze

Little Impact of Medicare ACOs on Low- and High-Value Revascularization Decisions

The M Word: Is Routine Transfemoral PCI Defensible in 2018?

Platelet Reactivity Linked With Ischemic Stroke Risk Post-DES Implantation: ADAPT-DES Substudy

Shortfalls in MI Care Hit Lowest Socioeconomic Groups the Hardest

Similar Rate of Radial Artery Occlusion After Manual and Mechanical Compression

TCTMD’s Top 10 Most Popular Stories for May 2018

STEMI Patients With Persistent Ischemia After PCI: A Potential Target for IABP?

ORBITA Deep Dive Highlights Treatment Choices, Social Media, and Ethics

DCBs for CAD in Certain Patients With Large Vessel De Novo Disease? DEBUT Says Yes

PiCSO therapy reduces infarct size in STEMI patients. Miracor Medical announces new publication at EuroPCR

‘Transient’ STEMI Patients Can Be Immediately Treated or Safely Deferred to Next Day

Modest Benefit of PCI Over Medical Therapy in Patients With ‘Grey Zone’ FFR Lesions

FFR in PCI for Stable CAD: Lasting Benefit Shown by FAME 2, SCAAR Data

New ORBITA Insights: Invasive Physiology Tests Track Closely With Ischemia, but Not Symptom Improvement

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content